Stephen E. BRAUN,Debasis MONDAL,Bruce A. BUNNELL,Narae LEE
申请号：
US16002604
公开号：
US20180280538A1
申请日:
2018.06.07
申请国别(地区):
US
年份:
2018
代理人:
摘要：
A composition of matter and method of treating HIV with mesenchymal stem cells (MSC) is disclosed. Specifically, MSCs are transduced with vectors incorporating an anti-viral fusion inhibitor, such as a C46-derived peptide or neutralizing antibody. The transduced MSCs are capable of expression the inhibitor and preventing HIV virus-cell fusion.
